Related Experiment Video
Updated: Jan 16, 2026

07:51
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
Published on: August 1, 2025
803
Behavioral Decoding Reveals Cortical Endocannabinoid Potentiation during Δ9-THC Impairment
Anthony English1,2, David Marcus3,2, Khushi Yadav3
1Department of Pharmacology, University of Washington School of Medicine, Seattle, WA, 98195, USA.
Biorxiv : the Preprint Server for Biology
|October 3, 2025
Summary
Delta-9-tetrahydrocannabinol (THC) disrupts natural mouse behaviors by altering brain activity in the medial prefrontal cortex (mPFC). This leads to motor impairments via changes in GABAergic activity and endocannabinoid release.
Area of Science:
- Neuroscience
- Behavioral Science
- Pharmacology
Background:
- The precise mechanisms by which delta-9-tetrahydrocannabinol (THC) affects natural behaviors are not fully understood.
- Investigating the neural underpinnings of THC-induced behavioral changes is crucial for understanding its effects.
Purpose of the Study:
- To elucidate how THC impairs natural behaviors in mice.
- To identify specific neural circuits and molecular pathways involved in THC-induced motor deficits.
Main Methods:
- Development of a video-monitored behavioral platform utilizing machine learning classifiers to analyze natural mouse behaviors.
- Infusion of THC into the medial prefrontal cortex (mPFC) and assessment of its effects on walking kinematics.
- Measurement of mPFC GABAergic activity and excitatory/inhibitory (E/I) balance.
- Closed-loop optogenetic stimulation of mPFC GABAergic neurons to investigate motor impairment.
- Measurement of endocannabinoid (eCB) release and CB1 receptor (CB1R) activity.
Main Results:
- THC infusion into the mPFC disrupted walking kinematics, indicative of impairment.
- THC increased mPFC GABAergic activity before walk initiation, altering the E/I balance.
- Optogenetic stimulation mimicking THC's effects exacerbated motor impairments.
- THC induced a transient potentiation of mPFC eCB release, linked to movement and CB1R-mediated synaptic inhibition.
Conclusions:
- THC modifies the mPFC E/I balance towards excitation through dynamic changes in eCB release.
- These neurochemical alterations induced by THC are directly responsible for behavioral impairments.
More Related Videos
Related Concept Videos
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
782
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
782
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
672
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
672
Drug Abuse and Addiction: Pharmacological Phenomena
1.1K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.1K

